{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T11:04:05Z","timestamp":1704798245963},"reference-count":32,"publisher":"Walter de Gruyter GmbH","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Carnitine palmitoyltransferase II (CPT-II) deficiency is an autosomal recessively inherited disorder involving the \u03b2-oxidation of long-chain fatty acids, which leads to rhabdomyolysis and subsequent acute renal failure. The clinical phenotype varies from a severe infantile form to a milder muscle form. Here, we report a 9-year-old boy referred to our hospital for the investigation of hematuria with a 2-day history of dark urine and malaise. As no erythrocytes in the microscopic examination of the urine and hemoglobinuria were present, myoglobinuria due to rhabdomyolysis was the most probable cause of dark urine. After excluding the other causes of rhabdomyolysis, with the help of metabolic investigations, the patient was suspected to have CPT-II deficiency, the most common cause of metabolic rhabdomyolysis. Our aim in presenting this case is to emphasize considering rhabdomyolysis in the differential diagnosis of dark urine in order to prevent recurrent rhabdomyolysis and renal injury.<\/jats:p>","DOI":"10.1515\/jpem-2016-0324","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T10:01:38Z","timestamp":1484301698000},"source":"Crossref","is-referenced-by-count":3,"title":["An ignored cause of red urine in children: rhabdomyolysis due to carnitine palmitoyltransferase II (CPT-II) deficiency"],"prefix":"10.1515","volume":"30","author":[{"given":"Engin","family":"Melek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma Derya","family":"Bulut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahriye","family":"Atm\u0131\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berna \u015eeker","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysun Karabay","family":"Bayaz\u0131t","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neslihan \u00d6nenli","family":"Mungan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","reference":[{"key":"ref241","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2007.09.015","article-title":"Clinical features and new molecular findings in carnitine palmitoyltransferase II (CPT II) deficiency","volume":"266","year":"2008","journal-title":"J Neurol Sci"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.mam.2004.06.004","article-title":"Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects","volume":"25","year":"2004","journal-title":"Mol Aspects Med"},{"key":"ref201","first-page":"619","article-title":"Studies of mechanisms and protective maneuvers in myoglobinuric acute renal injury","volume":"60","year":"1989","journal-title":"Lab Invest"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archneur.62.1.37","article-title":"Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects","volume":"62","year":"2005","journal-title":"Arch Neurol"},{"key":"ref21","first-page":"107","article-title":"Carnitine palmitoyltransferase II (CPT II) deficiency: genotype\u2013phenotype analysis of 50 patients","volume":"338","year":"2013","journal-title":"J Neurol Sci"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cca.2013.07.018","article-title":"Novel mutations in myopathic form of carnitine palmitoyltransferase II deficiency in a Chinese patient","volume":"425","year":"2013","journal-title":"Clin Chim Acta"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM199003223221207","article-title":"Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis","volume":"322","year":"1990","journal-title":"N Engl J Med"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.182.4115.929","article-title":"Muscle carnitine palmitoyltransferase deficiency and myoglobinuria","volume":"182","year":"1973","journal-title":"Science"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM199003223221207","article-title":"Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis","volume":"322","year":"1990","journal-title":"N Engl J Med"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2007.09.015","article-title":"Clinical features and new molecular findings in carnitine palmitoyltransferase II (CPT II) deficiency","volume":"266","year":"2008","journal-title":"J Neurol Sci"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00296-009-1221-z","article-title":"Exercise-induced rhabdomyolysis and transient loss of deambulation as outset of partial carnitine palmityl transferase II deficiency","volume":"31","year":"2011","journal-title":"Rheumatol Int"},{"key":"ref31","first-page":"907","article-title":"Rhabdomyolysis","volume":"65","year":"2002","journal-title":"Am Fam Physician"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cca.2013.07.018","article-title":"Novel mutations in myopathic form of carnitine palmitoyltransferase II deficiency in a Chinese patient","volume":"425","year":"2013","journal-title":"Clin Chim Acta"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00467-009-1223-9","article-title":"Rhabdomyolysis: a review, with emphasis on the pediatric population","volume":"25","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.mam.2004.06.004","article-title":"Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects","volume":"25","year":"2004","journal-title":"Mol Aspects Med"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1212\/01.WNL.0000078195.05396.20","article-title":"Effect of diet on exercise tolerance in carnitine palmitoyltransferase II deficiency","volume":"61","year":"2003","journal-title":"Neurology"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbrc.2014.04.084","article-title":"Functional analysis of iPSC-derived myocytes from a patient with carnitine palmitoyltransferase II deficiency","volume":"448","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"ref41","first-page":"619","article-title":"Studies of mechanisms and protective maneuvers in myoglobinuric acute renal injury","volume":"60","year":"1989","journal-title":"Lab Invest"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00467-009-1223-9","article-title":"Rhabdomyolysis: a review, with emphasis on the pediatric population","volume":"25","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/PEC.0000000000000127","article-title":"Carnitine palmitoyl transferase II deficiency in an adolescent presenting with rhabdomyolysis and acute renal failure","volume":"30","year":"2014","journal-title":"Pediatr Emerg Care"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archneur.62.1.37","article-title":"Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects","volume":"62","year":"2005","journal-title":"Arch Neurol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbrc.2014.04.084","article-title":"Functional analysis of iPSC-derived myocytes from a patient with carnitine palmitoyltransferase II deficiency","volume":"448","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1212\/01.WNL.0000078195.05396.20","article-title":"Effect of diet on exercise tolerance in carnitine palmitoyltransferase II deficiency","volume":"61","year":"2003","journal-title":"Neurology"},{"key":"ref191","first-page":"907","article-title":"Rhabdomyolysis","volume":"65","year":"2002","journal-title":"Am Fam Physician"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejim.2007.04.025","article-title":"Severe rhabdomyolysis with hypoglycemia in an adult patient with carnitine palmitoyltransferase II deficiency","volume":"19","year":"2008","journal-title":"Eur J Intern Med"},{"key":"ref101","first-page":"2925","article-title":"Carnitine-palmitoyltransferase 2 deficiency: novel mutations and relevance of newborn screening","volume":"146","year":"2008","journal-title":"Am J Med Genet A"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00296-009-1221-z","article-title":"Exercise-induced rhabdomyolysis and transient loss of deambulation as outset of partial carnitine palmityl transferase II deficiency","volume":"31","year":"2011","journal-title":"Rheumatol Int"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/PEC.0000000000000127","article-title":"Carnitine palmitoyl transferase II deficiency in an adolescent presenting with rhabdomyolysis and acute renal failure","volume":"30","year":"2014","journal-title":"Pediatr Emerg Care"},{"key":"ref181","first-page":"107","article-title":"Carnitine palmitoyltransferase II (CPT II) deficiency: genotype\u2013phenotype analysis of 50 patients","volume":"338","year":"2013","journal-title":"J Neurol Sci"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.182.4115.929","article-title":"Muscle carnitine palmitoyltransferase deficiency and myoglobinuria","volume":"182","year":"1973","journal-title":"Science"},{"key":"ref261","first-page":"2925","article-title":"Carnitine-palmitoyltransferase 2 deficiency: novel mutations and relevance of newborn screening","volume":"146","year":"2008","journal-title":"Am J Med Genet A"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejim.2007.04.025","article-title":"Severe rhabdomyolysis with hypoglycemia in an adult patient with carnitine palmitoyltransferase II deficiency","volume":"19","year":"2008","journal-title":"Eur J Intern Med"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/jpem.2017.30.issue-2\/jpem-2016-0324\/jpem-2016-0324.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2016-0324\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T01:41:35Z","timestamp":1619055695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2016-0324\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,1]]},"references-count":32,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1515\/jpem-2016-0324","relation":{},"ISSN":["2191-0251","0334-018X"],"issn-type":[{"value":"2191-0251","type":"electronic"},{"value":"0334-018X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1,1]]}}}